Structure-based drug design for diagnosis and treatment of neurological diseases

148.1K

views

50

authors

11

articles

Structure-based drug design for diagnosis and treatment of neurological diseases

148.1K

views

50

authors

11

articles

Editorial

24 January 2017

Editorial: Structure-Based Drug Design for Diagnosis and Treatment of Neurological Diseases

Rona R. Ramsay

and

Giuseppe Di Giovanni

2,857 views

4 citations

Editors

2

Giuseppe Di Giovanni

Department of Medical and Surgical Science, University of Magna Graecia

University of St Andrews

Impact

About

Monoamine neurotransmitters such as dopamine, noradrenaline, histamine and serotonin play a central role in the pathophysiology of major neuropsychiatric illnesses, such as anxiety and mood disorders, schizophrenia, autism-spectrum disorders, Parkinson’s disease, epilepsy, and dementias. The aim of this Research Topic is to highlight interdisciplinary research using drug design, data-mining, structure-based drug design, medicinal chemistry and biological investigation in vitro and in vivo disease models, with input from behavioral and genetic studies. In this issue we encourage submissions of basic and/or clinical studies and review papers that summarize current knowledge and point out important deficiencies in our current understanding of the important monoamines systems.

Monoamine neurotransmitters such as dopamine, noradrenaline, histamine and serotonin play a central role in the pathophysiology of major neuropsychiatric illnesses, such as anxiety and mood disorders, schizophrenia, autism-spectrum disorders, Parkinson’s disease, epilepsy, and dementias. The aim of this Research Topic is to highlight interdisciplinary research using drug design, data-mining, structure-based drug design, medicinal chemistry and biological investigation in vitro and in vivo disease models, with input from behavioral and genetic studies. In this issue we encourage submissions of basic and/or clinical studies and review papers that summarize current knowledge and point out important deficiencies in our current understanding of the important monoamines systems.

Download ebook

Share

Editors

Giuseppe Di Giovanni

Department of Medical and Surgical Science, University of Magna Graecia

University of St Andrews

Impact

148,119 Total views

110,521 Article views

32,804 Article downloads

4,794 Topic views

Published In

Journal Thumbnail

Frontiers in Neuroscience

Neuropharmacology

Journal Thumbnail

Frontiers in Pharmacology

Neuropharmacology

Journal Thumbnail

Frontiers in Psychiatry

Neuropharmacology

Journal Thumbnail

Frontiers in Neurology

Neuropharmacology

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic